Biomarkers that predict diabetic nephropathy: The long road from finding targets to clinical use

Diabetes

Volumn 61, Issue 12, 2012, Pages 3072-3073

  Klein, Jon ^a,b  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD99 ANTIGEN; CLUSTERIN; COLLAGEN; PROTEOME;

DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MASS SPECTROMETRY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PREDICTIVE VALUE; PRIORITY JOURNAL;

DIABETIC NEPHROPATHIES; HUMANS; PROTEOMICS;

EID: 84870363107     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1299     Document Type: Note

References (12)

1. Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006;368:1681-1688
2. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med 2003;348:2285-2293 (Pubitemid 36638102)
3. Perkins BA, Ficociello LH, Ostrander BE, et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol 2007;18:1353-1361 (Pubitemid 46536923)
4. Macisaac RJ, Jerums G. Diabetic kidney disease with and without albuminuria. Curr Opin Nephrol Hypertens 2011;20:246-257
5. Zürbig P, Jerums G, Hovind P, et al. Urinary proteomics for early diagnosis in diabetic nephropathy. Diabetes 2012;61:3304-3313
6. Villanueva J, Martorella AJ, Lawlor K, et al. Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age. Mol Cell Proteomics 2006;5:1840-1852 (Pubitemid 44688193)
7. Villanueva J, Shaffer DR, Philip J, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 2006;116: 271-284 (Pubitemid 43121812)
8. Quintana LF, Campistol JM, Alcolea MP, Bañon-Maneus E, Sol-González A, Cutillas PR. Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction. Mol Cell Proteomics 2009;8:1658-1673
9. Good DM, Zürbig P, Argilés A, et al. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics 2010;9:2424-2437
10. Rossing K, Mischak H, Dakna M, et al.; PREDICTIONS Network. Urinary proteomics in diabetes and CKD. J Am Soc Nephrol 2008;19:1283-1290
11. Merchant ML, Perkins BA, Boratyn GM, et al. Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol 2009;20:2065-2074
12. Fu Q, Schoenhoff FS, Savage WJ, Zhang P, Van Eyk JE. Multiplex assays for biomarker research and clinical application: translational science coming of age. Proteomics Clin Appl 2010;4:271-284